A. PCT (hr): | |||||
Patient (ID) | Drug | Micr. observed | qPCR* observed | Micr. LL | qPCR LL |
1 (OX007) | QN | 120 | - | 122 | 134 |
2 (OX005) | QN | 96 | - | 87 | 89 |
3 (OX006) | AS | 120 | - | 121 | 183 |
4 | QN; AP | - | - | 220 | 199 |
B. PRR 48 h (ratio, no units): | |||||
Patient (ID) | Drug | Micr. observed | qPCR * observed | Micr. LL | qPCR LL |
1 (OX007) | QN | 80 | 30 | 100 | 50 |
2 (OX005) | QN | 100 000 | 100 000 | 25 000 | 25 000 |
3 (OX006) | AS | 50 | 14 | 100 | 14 |
4 | QN; AP | 10 | 7 | 10 | 10 |
C. PCT 95 (hr): | |||||
Patient (ID) Drug | Drug | Micr. observed | qPCR * observed | Micr. LL | qPCR LL |
1 (OX007) | QN | 49 | 44 | 33 | 38 |
2 (OX005) | QN | 16 | 16 | 15 | 15 |
3 (OX006) | AS | 45 | 49 | 39 | 56 |
4 | QN; AP | 56 | 55 | 60 | 54 |